Home/Filings/4/0001415889-21-004998
4//SEC Filing

Ginascol John F 4

Accession 0001415889-21-004998

CIK 0000001800other

Filed

Oct 26, 8:00 PM ET

Accepted

Oct 27, 6:45 PM ET

Size

8.3 KB

Accession

0001415889-21-004998

Insider Transaction Report

Form 4
Period: 2021-10-27
Ginascol John F
Executive Vice President
Transactions
  • Exercise/Conversion

    Option (right to buy)

    2021-10-2745,7090 total
    Exercise: $47.00From: 2018-02-20Exp: 2025-02-19Common Shares (45,709 underlying)
  • Tax Payment

    Common shares without par value

    2021-10-27$128.13/sh29,588$3,791,110113,674 total
  • Exercise/ConversionSwap

    Common shares without par value

    2021-10-27$47.00/sh+45,709$2,148,323143,262 total
Footnotes (1)
  • [F1]Stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

Issuer

ABBOTT LABORATORIES

CIK 0000001800

Entity typeother

Related Parties

1
  • filerCIK 0001778075

Filing Metadata

Form type
4
Filed
Oct 26, 8:00 PM ET
Accepted
Oct 27, 6:45 PM ET
Size
8.3 KB